U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07949981) titled 'Celiac Versus Splanchnic Neurolysis in Abdominal Malignancies' on Sept. 17.
Brief Summary: To compare the analgesic efficacy, patient quality of life and safety profile of celiac plexus neurolysis versus splanchnic neurolysis in patients of abdominal malignancies.
Sixty patients suffering from abdominal malignancies. Patients in Group C were administered celiac plexus neurolysis while those in Group S were administered bilateral splanchnic neurolysis. The primary outcome was the pain score measured by the Visual analogue score at two, four and eight and twelve weeks following the procedure. The secondary outcome was improvement in ...